Document is current

Article History

Received: 4 August 2020

Accepted: 21 December 2020

First Online: 22 January 2021

Ethics approval and consent to participate

: This study reported in this manuscript was a survey of medical professionals to determine stated practice for the use of neoadjuvant systemic therapy in breast cancer. Bothe this survey and the ongoing prospective cohort study will not affect clinical care. Consequently, research ethics approval is not required and this has been confirmed by the Health Research Authority online decision tool (). A Trainee Lead was identified at each participating unit, who in turn identified a named supervising consultant to act as the principal investigator for registration purposes. The study lead, in consultation with the principal investigator to registered the audit at each site and obtained local audit approvals for study participation prior to commencing data collection. A copy of local approval is held by the NeST study team. Patient consent is not required, as no patient identifiable data are being recorded and there is no risk to patients.

: Not applicable, as outlined above; no patient identifiable data is collected or published.

: None declared.